פדיאסל

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

DIPHTHERIA TOXOID; FILAMENTOUS HAEMAGGLUTININ (FHA); FIMBRAE TUPES 2 + 3 (FIM); PERTACTIN (PRN); PERTUSSIS TOXOID VACCINE; POLIOVIRUS TYPE 1; POLIOVIRUS TYPE 2; POLIOVIRUS TYPE 3; PRP OF HAEMOPHILUS INFL. TYPE B; TETANUS TOXOID

MAH:

MEDICI MEDICAL LTD, ISRAEL

ATC_code:

J07CA

pharmaceutical_form:

תרחיף להזרקה

composition:

PERTACTIN (PRN) 3 MCG ML; DIPHTHERIA TOXOID 15 LF ML; TETANUS TOXOID 5 LF ML; PERTUSSIS TOXOID VACCINE 20 MCG ML; FILAMENTOUS HAEMAGGLUTININ (FHA) 20 MCG ML; FIMBRAE TUPES 2 + 3 (FIM) 5 MCG ML; POLIOVIRUS TYPE 1 40 DU ML; POLIOVIRUS TYPE 2 8 DU ML; POLIOVIRUS TYPE 3 32 DU ML; PRP OF HAEMOPHILUS INFL. TYPE B 10 MCG ML

administration_route:

תוך-שרירי

prescription_type:

אין צורך במרשם

manufactured_by:

SANOFI PASTEUR LTD, CANADA

therapeutic_group:

BACTERIAL AND VIRAL VACCINES, COMBINED

therapeutic_indication:

Pediacel is indicated for immunization of children at or above the age of 2 months and as a booster in children up to their 7th birthday against diphtheria, tetanus, whooping cough, poliomyelitis and invasive Haemophilus influenzae type b disease. In infants, three infectons are to be given intramuscularly at 2, 4 and 6 months of age followed by a booster at 18 months of age. Children who have had pertusis, tetanus, diphtheria or haemophilus influenzae type b invasive disease should still be immunized since these clinical infections do not always confer immunity. Children who have had natural pertussis can continue to receive pertussis - containing vaccines. Human immunodeficiency virus (HIV) infected persons HIV- infected individuals, both asymptomatic and symptomatic, should be immunized with Pediacel vaccine according to standard schedules.

authorization_date:

2014-06-30